The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity.

That’s why now’s the time to join the 9th CAR-TCR Summit: the industry’s definitive forum committed to progressing end-to-end cell therapy development. This year’s 2-day conference will accommodate in-depth tracks covering Discovery, Translation, Clinical Development, Early-Stage Manufacturing, Late-Stage Manufacturing, Analytical Development and Supply Chain & Clinical Operations.

This is your team’s one-stop shop for all functions to discover cutting-edge innovations, significant clinical data and gain insights into how to conquer the bottlenecks withholding optimal durability, accessibility, safety and cost-efficiency.

Join 200+ expert speakers and 1,000+ cell therapy experts to collaborate to achieve the shared goal of delivering these curative treatments to the ever-growing population of patients in need.

View the Preliminary Agenda to see a sneak peek at the speaker faculty, what’s new for 2024, session titles, who you will meet and much more!

View the Preliminary Agenda Now:

pre-launch brochure ss

“The science in this space is moving so quickly and this is such a tremendous opportunity to be made aware of how we can better serve patients with these terrible diseases. It is so critical to have this conference so the field can continue to evolve synergistically”
Lisa Joy Martin, Executive Director, Patient Safety, Kite Pharma, Past Attendee

CAR-TCR23-321 (1)
Partnership Opps (5)

A Sneak Peek at the 2024 Speakers:

Who Attended in 2023:

“This is always a high point in my year. I had a lot of opportunities to network and listen to high-quality talks and get some exciting ideas to bring back to the office”
Nelly Viseux, Senior Vice President - Process & Analytical Development & Clinical Manufacturing, bluebird bio, Past Attendee

What's New for 2024?

& Strategy

Hear the decision-making process behind investors and big pharma search and evaluation teams and discuss methods to facilitate market access and pipeline strategy.

Carl June
CAR-TCR Travel Fund Award 

This award, presented by Dr. Carl June himself, will enable selected academics to attend for free, to engage with the field and further advance their innovative research.

Solid Tumors

Battle the immunosuppressive tumor microenvironment, optimize armoring and combination strategies and boost penetration to ultimately transform anti-tumor responses.

Automation & Manufacturing Technology Focus Day

Hear how you can integrate automated processes at various stages of production to achieve operational excellence.

New Speaking Companies:

CAR-T - new speaking companies

Lead Partner

Expertise Partners

“Great topics and presenters covering newest updates in the field. A good combination and balance of presentations and panel discussions. The perfect size of exhibits and attendees”
Yan Wang, Director - Head of Cellular Process Development, bluebird bio, Past Attendee